Unlocking Success in Medical Device Innovation: The Essential Role of Data Integrity in Digital Transformation

Unlocking Success in Medical Device Innovation: The Essential Role of Data Integrity in Digital Transformation

The Importance of Data Integrity in Pharma R&D

Pharmaceutical R&D companies rely heavily on the data they produce and own. This data is pivotal to their value and operations. However, during digital transformation programs, such as transitioning to modern platforms like Veeva for regulatory information management (RIM), the preparation of legacy data often becomes an overlooked task. Ensuring data quality, integrity, completeness, and future fitness is essential for the new system to deliver its full potential.

Challenges in Data Migration

Moving terabytes of data to a new platform brings several challenges:

  • Data Quality:?Ensuring the data is accurate and consistent.
  • Data Integrity:?Maintaining and ensuring the accuracy and consistency of data over its lifecycle.
  • Data Completeness:?Ensuring all necessary data is present.
  • Fitness for Future Purpose:?Ensuring data remains relevant and usable in the new system.

Addressing these issues upfront or during migration is crucial for the success of the new platform.

Successful Data Migration in a Mid-Sized Pharma R&D Company

In a recent project involving Veeva and data migration specialists fme, a global mid-sized pharma organization embarked on a significant program to modernize its regulatory documentation and submission management capability. This required extensive content mapping and data enrichment.

The Role of fme

fme provided immediate value with their deep understanding of the target Veeva system and the necessary data preparation tasks. Being a certified Veeva partner, fme had expert knowledge of data clean-up, preparation, augmentation/enrichment, and validation required for successful migration.

fme Migration-Center

fme's proprietary platform, migration-center, facilitated the high-volume and complex content migration. It allowed data verification and preparation in a safe, validated environment, avoiding disruption to the live Regulatory Affairs system. This platform handled data translation efficiently through a series of deltas, reducing the risk associated with large-scale data migration.

Reduced Migration Time

Thanks to meticulous planning and the use of specialized tools, the migration was completed in 12 months – six months faster than typical for such comprehensive projects. The majority of the work was conducted offline, ensuring safety and efficiency.

The Value of fme’s Expertise

fme's value extends beyond technical expertise. Their understanding of regulatory processes and data in Life Sciences, combined with their ability to bridge technical and business teams, makes them exceptional partners in data migration projects.

A Certified Partnership

The successful implementation of the Veeva system was due to the collaborative approach taken by fme. Their close relationships with Veeva, the client, and other consultants ensured shared ownership and respect for project success.

Start Your Risk-Free Analysis

To ensure your migration is on the right path, consider a free 30-minute analysis with? me Ian Crone, VP Global Strategic Solutions at fme. My unique combination of sector understanding and technological knowledge offers unparalleled insights into complex transformation initiatives in the highly regulated pharma industry.

Ensure your digital transformation upholds data integrity and secures long-term potential by leveraging the expertise of fme and their proven methodologies.

Contact me [email protected]?so that I can discuss your challenges with you and help you start your migration journey on the right path.

要查看或添加评论,请登录

Ian Crone的更多文章

社区洞察

其他会员也浏览了